CMS launches new data pilot program aimed at clinicians

Just a day after announcing three new payment proposals for 2020, CMS introduced a new pilot program for clinicians focusing on data.

The program, dubbed Data at the Point of Care (DPC), was announced at the White House Blue Button Developers Conference and is part of CMS’ MyHealthEData initiative to provide patients digital access to their health information.

The program gives clinicians access to claims data through Medicare’s Blue Button data, filling information gaps and offering a more complete picture of a patient’s health and history.

“The sharing of data and interoperability underpin this entire move to value in healthcare and innovation. Without access to their own data, patients lack the information—and therefore the power and ability—to shop around for services,” CMS Administrator Seema Verma said in a speech at the conference July 30.

Blue Button 2.0 was established by CMS last year to create a claims-based API for Medicare beneficiaries, allowing them to connect their data to apps and other tools created by developers.

“Clinicians will be able to access the DPC pilot data directly within their workflow, without needing to log into another application,” the announcement reads.

The clinicians in the pilot will be able to request the claims data of a Medicare beneficiary from CMS to get a “full snapshot of their care,” including data from other providers where the patient has received care. The claims data will be access through an industry-standard application programming interface (API) using Health Level 7’s Fast Healthcare Interoperability Resource (FHIR®) standard, which is a popular interoperability protocall, according to CMS.

“Technology, coupled with open data sharing, is how we will improve value, control costs and keep patients healthy while ensuring a solvent Medicare program for generations to come,” CMS Administrator Seema Verma said in a statement.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.